Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

TWi Pharmaceuticals Inc

+ Add to Watchlist

4180:TT

205.00 TWD 2.00 0.97%

As of 23:02:26 ET on 03/31/2015.

Snapshot for TWi Pharmaceuticals Inc (4180)

Open: 208.00 Day's Range: 205.00 - 208.00 Volume: 108,000
Previous Close: 207.00 52wk Range: 187.50 - 324.00 1-Yr Rtn: -16.29%

Stock Chart for 4180

No chart data available.
  • 4180:TT 205.00
  • 1D
  • 1M
  • 1Y
207.00
Interactive 4180 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4180

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 35.2850
Relative P/E vs. TWOTCI -
Earnings Per Share (TWD) (ttm) -6.7521
Est. EPS (TWD) (12/2015) 5.8240
Est. PEG Ratio -
Market Cap (M TWD) 23,298.75
Shares Outstanding (M) 113.10
30 Day Average Volume 406,409
Price/Book (mrq) 6.1384
Price/Sale (ttm) 50.9364
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4180

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4180

TWi Pharmaceuticals Inc is a pharmaceutical company. The Company develops, manufactures, and commercializes high barrier generic prescriptions products and new drug products to fulfill unmet medical needs.

Chen J Chih-MingChairmanChen Chih-Kuang "Kevin"President
Tina GuilderPresident:USAHo I-Hua "Eva"Chief Financial Officer
More Company Profile & Key Executives for 4180

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil